Oncologynews (@Oncologynewspro) / Twitter
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
Additional capecitabine use in early-stage triple negative breast cancer patients receiving standard chemotherapy: a new era? A meta-analysis of randomized controlled trials | BMC Cancer | Full Text
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
PDF) Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
PDF) Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer
PDF) A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study – topic of research paper in Clinical
Metronomic chemotherapy in breast cancer | Semantic Scholar
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept | Scientific Reports
Overall survival of metronomic capecitabine and best supportive care... | Download Scientific Diagram
Metronomic capecitabine maintenance extends DFS in triple-negative breast cancer
The Lancet al Twitter: "Phase 3 trial suggests the addition of metronomic adjuvant capecitabine to chemoradiotherapy significantly improved failure-free survival in patients with high-risk locoregionally advanced nasopharyngeal carcinoma, with a ...
PDF) Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients
PDF) Efficacy and Toxicity of Metronomic Capecitabine in Advanced Hepatocellular Carcinoma *
Overall survival of metronomic capecitabine and best supportive care... | Download Scientific Diagram
Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial - ScienceDirect
A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer | Trials | Full Text
Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all?: Trends in Cancer
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure - Digestive and Liver Disease
PDF) Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study | Rita Golfieri and Franco Trevisani - Academia.edu
